IBDEI0HU ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8328,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,8328,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,8328,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,8329,0)
 ;;=136.3^^35^483^51
 ;;^UTILITY(U,$J,358.3,8329,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8329,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,8329,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,8329,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,8330,0)
 ;;=601.9^^35^483^56
 ;;^UTILITY(U,$J,358.3,8330,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8330,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,8330,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,8330,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,8331,0)
 ;;=590.80^^35^483^57
 ;;^UTILITY(U,$J,358.3,8331,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8331,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,8331,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,8331,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,8332,0)
 ;;=711.00^^35^483^58
 ;;^UTILITY(U,$J,358.3,8332,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8332,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,8332,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,8332,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,8333,0)
 ;;=461.9^^35^483^60
 ;;^UTILITY(U,$J,358.3,8333,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8333,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,8333,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,8333,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,8334,0)
 ;;=473.9^^35^483^59
 ;;^UTILITY(U,$J,358.3,8334,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8334,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,8334,1,5,0)
 ;;=5^Sinusitis Chronic
 ;;^UTILITY(U,$J,358.3,8334,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,8335,0)
 ;;=091.0^^35^483^65
 ;;^UTILITY(U,$J,358.3,8335,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8335,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,8335,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,8335,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,8336,0)
 ;;=097.0^^35^483^63
 ;;^UTILITY(U,$J,358.3,8336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8336,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,8336,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,8336,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,8337,0)
 ;;=094.9^^35^483^64
 ;;^UTILITY(U,$J,358.3,8337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8337,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,8337,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,8337,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,8338,0)
 ;;=097.9^^35^483^62
 ;;^UTILITY(U,$J,358.3,8338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8338,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,8338,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,8338,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,8339,0)
 ;;=463.^^35^483^66
 ;;^UTILITY(U,$J,358.3,8339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8339,1,4,0)
 ;;=4^463.
 ;;^UTILITY(U,$J,358.3,8339,1,5,0)
 ;;=5^Tonsillitis
 ;;^UTILITY(U,$J,358.3,8339,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,8340,0)
 ;;=130.9^^35^483^67
 ;;^UTILITY(U,$J,358.3,8340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8340,1,4,0)
 ;;=4^130.9
 ;;^UTILITY(U,$J,358.3,8340,1,5,0)
 ;;=5^Toxoplasmosis NOS
 ;;^UTILITY(U,$J,358.3,8340,2)
 ;;=^120695
 ;;^UTILITY(U,$J,358.3,8341,0)
 ;;=011.90^^35^483^68
 ;;^UTILITY(U,$J,358.3,8341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8341,1,4,0)
 ;;=4^011.90
 ;;^UTILITY(U,$J,358.3,8341,1,5,0)
 ;;=5^Tuberculosis
 ;;^UTILITY(U,$J,358.3,8341,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,8342,0)
 ;;=614.2^^35^483^69
 ;;^UTILITY(U,$J,358.3,8342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8342,1,4,0)
 ;;=4^614.2
 ;;
 ;;$END ROU IBDEI0HU
